Title:A Case of de novo Annular-plaque Type Psoriasis Following Oxford-
AstraZeneca COVID-19 Vaccination
Volume: 18
Issue: 4
Author(s): Namrata Chhabra*Anju George
Affiliation:
- Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh 492099, India
Keywords:
Psoriasis, COVID-19 vaccine, annular, astrazeneca, hypertension, psoriasis.
Abstract:
Background: There have been increasing reported cases of new-onset or aggravation of
pre-existing dermatoses after the implementation of COVID-19 vaccination.
Case Presentation: An elderly male was presented with multiple annular scaly plaques all over the
body two weeks following administration of the first dose of Oxford-AstraZeneca COVID-19 vaccine.
The lesions further aggravated after taking the second dose of the vaccine. The clinical and
histopathology features were suggestive of annular plaque psoriasis.
Conclusion: We report this first case of de novo plaque psoriasis following the Oxford-
AstraZeneca COVID-19 vaccine, and it signifies a potential side effect of autoimmune reactivation
after COVID vaccination.
